Method for treating ocular hypertension
Details for Australian Patent Application No. 2002346562 (hide)
Event Publications
13 March 2003 Complete Application Filed
Priority application(s): 60/400,504 02.08.02 US; 60/338,117 03.12.01 US
21 August 2003 Application Open to Public Inspection
Published as AU-A-2002346562
16 March 2006 Assignment before Grant
Merck & Co., Inc.; Merck Frosst Canada & Co. The application has been assigned to Merck & Co., Inc.; Merck Frosst Canada Ltd. Assignments before Grant, Section 113
6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002346563-HIGH SURFACE AREA CARBON COMPOSITES
2002346561-EP4 receptor agonist, compositions and methods thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser